Equities research analysts at HC Wainwright started coverage on shares of Spectral AI (NASDAQ:MDAI – Get Free Report) in a note issued to investors on Thursday, Benzinga reports. The firm set a “buy” rating and a $3.50 price target on the stock. HC Wainwright’s price target points to a potential upside of 83.25% from the company’s current price.
Spectral AI Trading Up 2.1 %
Spectral AI stock opened at $1.91 on Thursday. Spectral AI has a 52-week low of $1.52 and a 52-week high of $19.50. The stock has a fifty day moving average price of $1.72 and a two-hundred day moving average price of $2.02.
Spectral AI (NASDAQ:MDAI – Get Free Report) last announced its earnings results on Tuesday, May 7th. The company reported ($0.19) earnings per share for the quarter. The firm had revenue of $6.33 million during the quarter.
Institutional Trading of Spectral AI
Spectral AI Company Profile
Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.
Further Reading
- Five stocks we like better than Spectral AI
- How to Read Stock Charts for Beginners
- Watch These 4 Overbought Stocks As Market Rotation Continues
- Investing In Automotive Stocks
- Chip Stocks: Bargain Buys or Looming Bust?
- What is the Nikkei 225 index?
- Gold Hits New High: 3 Stocks Investors Should Watch
Receive News & Ratings for Spectral AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral AI and related companies with MarketBeat.com's FREE daily email newsletter.